BamSEC and AlphaSense Join Forces
Learn More

Calidi Biotherapeutics Inc.

NYSE American: CLDI    
Share price (12/23/24): $1.41    
Market cap (12/23/24): $18.4 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 13 pages Placement Agency Agreement November 14, 2024
12/34/56
EX-10.2
from 8-K 13 pages Placement Agency Agreement October 23, 2024
12/34/56
EX-10.1
from 8-K 32 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 44 pages At the Market Offering Agreement
12/34/56
EX-10.3
from 8-K 4 pages Intellectual Property Assignment Agreement
12/34/56
EX-10.1
from 8-K 10 pages Subscription Agreement
12/34/56
EX-10.2
from 8-K 12 pages Material contract
12/34/56
EX-10.2
from 8-K 3 pages Material contract
12/34/56
EX-10.1
from 8-K 7 pages Material contract
12/34/56
EX-10.1
from 8-K 11 pages Re: Series B and C Warrant Exercise Agreement to Whom It May Concern
12/34/56
EX-10.51
from S-1/A 2 pages Third Amendment to Convertible Promissory Note
12/34/56
EX-10.50
from S-1/A 18 pages Calidi Biotherapeutics, Inc. and Equiniti Trust Company, LLC (F/K/a American Stock Transfer & Trust Company, LLC) as Warrant Agent Warrant Agency Agreement Dated as of April __, 2024 Warrant Agency Agreement
12/34/56
EX-10.49
from S-1/A 3 pages Date: April [__], 2024 To: Calidi Biotherapeutics, Inc. Ladenburg Thalmann & Co. Inc. Each Purchaser as Identified on the Signature Page of the Securities Purchase Agreement to Whom It May Concern
12/34/56
EX-10.38
from S-1/A 38 pages Securities Purchase Agreement
12/34/56
EX-10.48
from S-1/A 4 pages Leak-Out Agreement
12/34/56
EX-10.38
from S-1/A 38 pages Securities Purchase Agreement
12/34/56
EX-10.38
from S-1/A 34 pages Securities Purchase Agreement
12/34/56
EX-10.47
from S-1/A 3 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. [*****] Indicates That Information Has Been Redacted or Omitted
12/34/56
EX-10.46
from S-1/A 3 pages First Amendment to Convertible Promissory Note
12/34/56
EX-10.38
from S-1/A 35 pages Securities Purchase Agreement
12/34/56